Difference between revisions of "Cancer staging systems"

Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 75: Line 75:
***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref>
***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref>
*[[Margin status]] usually does not affect the tumour stage.
*[[Margin status]] usually does not affect the tumour stage.
**Exception:
**[[Prostate adenocarcinoma]] - on a practical level bladder neck margin positivity usually up stages, see ''[[bladder neck invasion]]''.
***[[Prostate adenocarcinoma]] - bladder neck margin positivity.


===Nodal stage===
===Nodal stage===
{{Main|Lymph node metastasis}}
*[[lymph node metastasis|Lymph node involvement]].
*[[lymph node metastasis|Lymph node involvement]].
*Positive lymph nodes (without mets) often upstage to ''stage III''.
*Positive lymph nodes (without mets) often upstage to ''stage III''.
48,474

edits

Navigation menu